MagCyte

MAGCYTE team is breaching the frontier in cancer detection with MAGCYTE ONE, an advanced medical device that detects the Circulating Tumor Cells, also known as CTCs, responsible for tumor metastasis, right in the beginning of the tumor growth, it is possible to diagnose cancer up to 4 years before it is detectable with imaging techniques, and to eliminate the tumor in an early stage. MAGCYTE ONE does this by filtering CTCs from blood samples, marking them with cancer-seeking immuno-magnetic markers and analyzing them with its state-of-art integrated magnetic sensors.

By entering the fast-growing market of CTC technology with our unique combination of microfluidics, microelectronics and magnetic sensors, MAGCYTE ONE will be able to make a difference and save millions of lives!